July 30 (Bloomberg) -- Alexion Pharmaceuticals, the drugmaker whose blood-disease treatment is among the world’s most expensive medicines, engaged Goldman Sachs as an adviser as it prepares for a possible takeover offer from Roche, said people with knowledge of the matter. Cristina Alesci reports on Bloomberg Television's "Money Moves." (Source: Bloomberg)
Shell CEO Sees Oil at `Much Higher Levels' in Long Term
Jan. 29 -- Royal Dutch Shell Plc Chief Executive Officer Ben Van Beurden said "the fundamentals of supply and demand will reassert themselves" and "oil prices will revert to much higher levels" in the long term.
He spoke with Mark Barton on Bloomberg Television's "Countdown" after Shell reported lower-than-expected fourth-quarter profit.
Shell 4Q Adjusted Profit $3.3B; Est. $4.1B
Low Interest Rates Driving Real Estate Demand: Tonckens